Tiếng Việt
8 (1) 2018
The initial study of EBNA-2 polymorphisms in nasopharyngeal carcinoma in Vietnam
Corresponding author:Abstract
system. EBNA-2 has 4 variants including E2-A, E2-B, E2-C and E-2D, of which E2-A and E2-C are the characterized variants for NPC. This study aimed to evaluate the variations of EBNA-2 in NPC biopsy samples of Vietnamese patients. This initial study used 10 biopsy samples, which were positively confirmed to NPC, collected from Cho Ray Hospital. Nested PCR – nucleotide sequencing was applied to analyze the variants of EBNA-2. The results showed that 8 out of 10 samples, accounting for 80%, were positive to EBNA-2. Additionally, only two variants, E-2A and E-2C were detected in our study, in which, E2-A subtype was identified as the predominant subtype. These findings would provide initial data about potential contribution of EBNA-2 polymorphisms to etiology of NPC in Vietnamese population.
Keywords
References
Cohen, J. I., Wang, F., & Kieff, E. (1991). Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Journal of Virology, 65, 2545-2554.
da Costa, V. G., Marques-Silva, A. C., & Moreli, M. L. (2015). The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: A meta-analysis of observational studies. Systematic Reviews, 13, 4-46.
Dai, W., Zheng, H., Cheung, A. K., & Lung, M. L. (2016). Genetic and epigenetic landscape of nasopharyngeal carcinoma. Chinese Clinical Oncology, 5(2), 16-28.
Henkel, T., Ling, P. D., Hayward, S. D., & Peterson, M. G. (1994). Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal binding protein J kappa. Science, 265, 92-95.
Hsieh, J. J., Henkel, T., Salmon, P., Robey, E., Peterson, M. G., & Hayward, S. D. (1996). Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Molecular and Cellular Biology, 16(3), 952-959.
Ko, Y. H. (2015). EBV and human cancer. Experimental & Molecular Medicine, 47(1), e130.
Kwok, H., Wu, C. W., Palser, A. L., Kellam, P., Sham, P. C., Kwong, D. L., & Chiang, A. K. (2014). Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. Journal of Virology, 88(18), 10662-10672.
Lo, K. W., To, K. F., & Huang, D. P. (2004). Focus on nasopharyngeal carcinoma. Cancer Cell, 5(5), 423-428.
McDermott, A. L., Dutt, S. N. & Watkinson, J. C. (2001). The aetiology of nasopharyngeal carcinoma. Clinical Otolaryngology, 26(2), 82-92.
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995). Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. New England Journal of Medicine, 333(11), 693-698.
Tsao, S. W., Yip, Y. L., Tsang, C. M., Pang, P. S., Lau, V. M., Zhang, G., & Lo, K. W. (2014). Etiological factors of nasopharyngeal carcinoma. Oral Oncology, 50(5), 330-338.
Wang, X., Wang, Y., Wu, G., Chao, Y., Sun, Z., & Luo, B. (2012). Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas. Virology Journal, 9, 49.
Wu, G., Liu, X., Liu, S., Shu, J., Sun, Z., & Luo, B. (2015). Epstein-Barr Virus EBNA-2 Polymorphic Patterns in Nasopharyngeal Carcinoma in Southern China. Intervirology, 58(6), 386-392.
Yang, X. R., Diehl, S., Pfeiffer, R., Chen, C. -J., Hsu, W. -L., Dosemeci, M., … Hildesheim, A. (2005). Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiology, Biomarkers & Prevention, 14(4), 900-905.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.